Mepolizumab for severe eosinophilic asthma: a comparison of efficacy in children, adolescents, and adults

Pneumologie 2019; 73(S 01)
DOI: 10.1055/s-0039-1677972

Freie Vorträge (FV DGP 2) – Sektion Pädiatrische Pneumologie

Freie Vorträge der Sektion Pädiatrische Pneumologie

Georg Thieme Verlag KG Stuttgart · New York

A Gupta

¹Department of Paediatric Respiratory Medicine, Kingʼs College Hospital & Kingʼs College London

,

J Steinfeld

¹Department of Paediatric Respiratory Medicine, Kingʼs College Hospital & Kingʼs College London

,

RG Price

²Clinical Statistics, Gsk, Stevenage, Hertfordshire, UK

,

J Azmi

³Respiratory Therapeutic Area, Gsk, Stockley Park, Uxbridge, UK

,

E Bradford

⁴Respiratory Therapeutic Area, Gsk, Research Triangle Park, Nc, USA

,

S Yancey

⁴Respiratory Therapeutic Area, Gsk, Research Triangle Park, Nc, USA